A genetically encoded bifunctional enzyme mitigates redox imbalance and lipotoxicity via engineered Gro3P-Glycerol shunt.

Pan X, Munan S, Zuckerman AL, Pon A, Violante S, Cross JR, Shah H, Cracan V

Is the upper arc or lower arc of lordosis more important in avoiding mechanical complications after adult spinal deformity surgery?

Jain H, Younus I, Gangavarapu LS, Chanbour H, Ahluwalia R, Zeoli T, Wegner AM, Lugo-Pico JG, Abtahi AM, Stephens BF, Zuckerman ASL

Deprescribing 5-Aminosalicytes in Patients with Ulcerative Colitis on Concomitant Advanced Therapy: A Qualitative Analysis.

Cruchelow KR, Bonnet KR, Zuckerman AD, Schlundt DG, Horst SN

Deutetrabenazine treatment outcomes with doses above U.S. Food and Drug Administration maximum approved doses in Huntington's disease chorea: A dual-site analysis.

Dodson K, Livezey S, Denson B, Choi L, DeClercq J, Zuckerman AD, Johnson K

Pharmacist tailored monitoring for patients initiating encorafenib and binimetinib combination therapy.

Looney BD, White SG, DeClercq J, Zuckerman AD, Choi L, Shah NB, Whelchel KW

4-1BB stimulation with concomitant inactivation of adenosine A2B receptors enhances CD8+ T cell antitumor response.

Ahn J, Xie P, Chen S, Shi G, Fan J, Zhang M, Tang H, Zuckerman AR, Fang D, Wan Y, Kuzel TM, Zhang Y, Zhang B

Implementation of an electronic early treatment assessment and monitoring questionnaire for oral anticancer medication.

Bui T, Looney B, DeClercq J, Lynch B, Whelchel K, Nelson S, Zuckerman A

Integrated health system pharmacy role in adherence, persistence, and adverse effect management for oral chronic lymphocytic leukemia therapy.

Wyatt H, White S, Holloway H, DeClercq J, Zuckerman AD, Choi L, Xue M, Carr K, Challgulla S, Yang K, Renfro C

Getting to specialty treatment in dermatologic inflammatory conditions: Treatment requirements and patient journey.

Bowles MG, Zuckerman AD, DeClercq J, Choi L, Ellis M, Renfro CP

Ultra-complex specialty medications: Meeting the challenges of significant medication requirements through an integrated specialty pharmacy model.

Renfro CP, Donald DR, Kibbons AM, Littlejohn MD, Danielle Bryan E, Nix R, Cherry E, Zuckerman AD

Tissue-specific modulation of NADH consumption as an anti-aging intervention in Drosophila.

Yadav S, Pan X, Li S, Martin PL, Hoang N, Chen K, Karhadkar A, Malhotra J, Zuckerman AL, Munan S, Klose MK, Wang L, Cracan V, Parkhitko AA

How relations between early reading skills and third-grade mathematics outcomes vary across distribution: A quantile regression approach.

Zhu Z, Zuckerman AP, Shero JA, Willcutt EG, Thompson LA, Petrill SA

Iron regulatory protein 1 is required for the propagation of inflammation in inflammatory bowel disease.

Fahoum L, Moshe-Belisowski S, Zaydel K, Ghatpande N, Guttmann-Raviv N, Zhang W, Li K, Tong WH, Nyska A, Waterman M, Weisshof R, Zuckerman A, Meyron-Holtz EG

A primer on copay accumulators, copay maximizers, and alternative funding programs.

Choi D, Zuckerman AD, Gerzenshtein S, Katsivalis KV, Nichols PJ, Saknini MC, Schneider MP, Taylor P, Dusetzina SB

Evaluating patient-reported adherence and outcomes in specialty disease states: A dual-site initiative.

Bryan ED, Renfro CP, Anguiano RH, Kumor L, DeClercq J, Choi L, Zuckerman AD